Search
selexipag (Uptravi)
Indications:
- pulmonary hypertension
Adverse effects:
- headache
- diarrhea
- nausea/vomiting
- jaw pain
- myalgia
- leg pain
- flushing
Mechanism of action:
- IP prostacyclin receptor agonist
- vasodilator agent
- relaxes
Interactions
drug adverse effects of antihypertensive agents
General
pulmonary agent
receptor agonist
vasodilator agent
References
- FDA News Release. December 22, 2015
FDA approves new orphan drug to treat pulmonary arterial
hypertension.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm478599.htm
- Sitbon O, Channick R, Chin KM et al.
Selexipag for the treatment of pulmonary arterial hypertension.
N Engl J Med 2015 Dec 24; 373:2522
PMID: 26699168
http://www.nejm.org/doi/full/10.1056/NEJMoa1503184